What this ad does well
The bulking-and-cutting frame is the most interesting thing here, because it speaks to guys who already think in training phases instead of to a general weight-loss audience. The opener is a question, and the treadmill scene matches it. The script stacks the convenience points the target viewer cares about (once a day, no injections, no in-person visits, no insurance required) in quick succession. The copy is unusually clear about price, splitting the medication cost from the membership fee, so nobody lands on the page surprised.
What's missing
The ad says “Guys are losing up to 20% of their body weight,” while the footnote on screen describes a 13.6% average in the study, so the headline number and the average sit far apart. That's where a careful viewer will stop trusting it. If you make one like this, lead with the average the footnote supports and let a real customer story carry the bigger result. The bulking angle also deserves one concrete moment (the end of a cut, a meet, a beach trip) so the viewer can picture when they'd use it.
Beat by beat
- 0-4s
A man runs on a treadmill under the question about taking Wegovy for bulking and cutting seasons.It calls out a gym-going audience and frames the product in their language.
- 4-12s
The product box appears with the line that it's the first FDA-approved GLP-1 pill for weight loss, as the ad states, with a study footnote.It gives the viewer a reason to see this as new rather than another injection.
- 12-22s
Convenience points (no injections, no insurance required) and the up-to-20% line with footnotes.It stacks reasons and a result before the viewer scrolls away.
- 22-30s
A call to take the online consultation, then a simulated intake screen asking how much weight you want to lose.It previews the first question so the tap feels like starting, not signing up.
The offer
Medication as low as $149 a month if prescribed, plus a required membership at $39 for the first month and $149 a month after.
Where it sends people
The ad sends people to the Wegovy consultation page, a focused entry page whose hero holds the first of three intake questions (pills, injections or a provider recommendation). Right under it, the range carousel shows every medication with a from-price per month, which pays off this ad's price-led copy directly. A membership section then lists what the separate fee covers, and a dosing explainer sets month-by-month expectations before the FAQ. The bulking-and-cutting angle doesn't carry into the page, which speaks to weight loss more broadly, so the hand-off is strong on price and weaker on the hook.
The page it sends people to: How Hims's Wegovy page shows price, membership and dosing up front
Hims's Wegovy consultation entry page, a focused landing page whose hero holds the first of three intake questions. Below it come a medication carousel with monthly from-prices, an outcome block, membership inclusions, benefit cards, a dosing explainer and an FAQ. One ad in the Fluid library sends people here, a price-led video about the Wegovy pill.
How the page is built
- 01
Announcement barOne line of price positioning answers whether this is affordable before anything else.
- 02
HeaderA logo-only header keeps the visitor on the page with no navigation to wander into.
- 03
HeroA warm portrait with a floating product card and a white question card asks the first intake question, answering how to start.
- 04
Range carouselMedication cards with Rx tags, from-prices, generic names and safety links answer what's available and what it costs.
- 05
Outcome blockA portrait, three check claims and an outcome-stat callout answer what results the brand describes.
- 06
MembershipImage tiles and five check rows answer what the separate membership fee includes.
- 07
Benefit-claim carouselDark cards pairing claims with simple charts answer why this program rather than going it alone.
- 08
Dosing explainerAn example chart of monthly dose increases and four numbered steps answer what the first months look like.
- 09
FAQA long accordion beside a Get Started button answers the remaining practical questions.
- 10
FooterA legal note, app card and link columns close the page.
The first fixes we would make
- The ad's bulking-and-cutting angle doesn't appear anywhere on the page, so gym-going visitors land on general weight-loss messaging. Add a short section or hero variant that speaks to training seasons for traffic from that ad.
- There's no customer proof, only claims and charts. A few customer stories with their own timelines, placed after the dosing explainer, would show what the months actually felt like.
Read the full breakdown of this page
Three hooks you could test
- Show a specific moment of use. “What if your next cut started with one pill in the morning?”
- Call out the habit you're replacing. “Done counting every macro by hand?”
- Sell the outcome. “Walk into summer at the weight you planned for in January.”
What to borrow for your brand
- Frame a broad product in the language of one specific audience (here, training seasons) so the right people feel called out.
- Split every cost into its parts in the copy (product, membership, first month) so the landing page never surprises anyone.
- End the video on the first intake question so the viewer has already started before they tap.
Transcript
What would happen if you took Wegovi to help with your bulking and cutting seasons? You'd get the 1st FDA approved GLP one pill for weight loss. Clinically proven to promote weight loss and taken only once a day, no injections, no in-person visits, no insurance required. Guys are losing up to 20% of their body weight, thanks to the once daily weekovy pill with hymns. The sooner you start, the sooner you start seeing results. Take the online consultation to get started today.
Text on screen
- What would happen if
- you took Wegovy®
- NOC 0169 4415-11
- wegovy® 1.5 mg
- (semaglutide) Tablets
- 30 tablets
- to help with your bulking
- and cutting seasons
- * 15 mu
- You'd get the first FDA-approved
- GLP-1 pill for weight loss
- NOC 0165-4415-31
- wegovy* 1.5 mg
- Clinically proven to promote weight loss'
- and taken only once a day
- Actor portrayal
- *In a 71-week elinical study of Wegory" oral semaglutide (25eng), adults with overweight
- or obesity lost on avg. 13.6% body weight alongside diet and exercise, Individual results may vary.
- Stopping treatment may result in weight regain.
- Clinically proven to promote weight loss
- *In a 71-woek clinical study of Wegory" oral semaglutide (25eg), adults with overweight
- or obesity lost on avg. 13.6% body weight alongside diet and exercie, Individual results may vary.
- No injections
- No insurance required
- Guys are losing up to
- 20% of their body weight:
- People lost an average of 14% body weight
- at 64 weeks in a clinical trial of Wegovy®
- *in a 7-week clinical study of Wegov" oral semaglutide (25mg), 27.9% of aduits with overweight
- or obesity lost 220% body weight at wetk 64, alongside diet and warcise, individual results may vary.
- 20% of their body weight*
- at 64 weeks in a clinical trial of Wegovy•
- *In a 71-week clinical study of Wegovy" oral semaglutide (25mg), 27.9% of adults with overweight
- or obesity lost 220% body weight at week 64, alongside diet and exercise, Individual results may vary.
- Futur
- 80 tablets
- Thanks to the once-daily
- Wegovy Pill with Hims
- The sooner you start,
- the sooner you start seeing results
One of 25 Hims ads in the Fluid Inspiration Library, captured from the Meta Ad Library on Oct 20, 2026. We record that an ad ran publicly, not how it performed.